Brief: Maat Pharma End-June Cash And Cash Equivalents At Eur 38.4 Million

Maat Pharma SA

28/07/2022 18:43

July 28 (Reuters) - Maat Pharma SA  MAAT.PA :
    * Q2 REVENUE 200,000 EUR
    * AS OF JUNE 30, 2022, CASH AND CASH EQUIVALENTS WERE EUR
38.4
MILLION
    * COMPANY BELIEVES IT HAS SUFFICIENT CASH TO COVER NEEDS OF
DEVELOPMENT PROGRAMS UP UNTIL END OF Q3 OF 2023

Source text for Eikon:  ID:nBw3Qlv9Va 
Further company coverage:  MAAT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))